NCT02135874 · OUTCOME
4-week Mortality Rate
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- At 4 weeks
What was measured
Number of participants who died after 4 weeks of treatment.
Groups in this outcome
Treatment (Combination Chemotherapy)
See Detailed Description. Clofarabine: Given IV Cytarabine: Given IV Dexamethasone: Given IV Idarubicin: Given IV Rituximab: Given IV Sorafenib: Given PO Sorafenib Tosylate: Given PO Vincristine: Given IV Vincristine Sulfate: Given IV
| Group | Source count |
|---|---|
| Treatment (Combination Chemotherapy) | 16 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Treatment (Combination Chemotherapy) | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- denoms
- counts
- group Id
- OG000
- value
- 16
- units
- Participants
- description
- Number of participants who died after 4 weeks of treatment.
- groups
- description
- See Detailed Description. Clofarabine: Given IV Cytarabine: Given IV Dexamethasone: Given IV Idarubicin: Given IV Rituximab: Given IV Sorafenib: Given PO Sorafenib Tosylate: Given PO Vincristine: Given IV Vincristine Sulfate: Given IV
- id
- OG000
- title
- Treatment (Combination Chemotherapy)
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- At 4 weeks
- title
- 4-week Mortality Rate
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle